Effect of tissue shrinkage on histological tumour-free margin after excision of basal cell carcinoma

Hudson-Peacock, 1995, Relation between size of skin excision, wound and specimen, J Am Acad Dermatol, 32, 1010, 10.1016/0190-9622(95)91341-6

Silverman, 1992, Verification of a formula for determination of pre-excision surgical margins from fixed-tissue melanoma specimens, J Am Acad Dermatol, 27, 214, 10.1016/0190-9622(92)70173-D

Golomb, 1991, Determination of pre-excision surgical margins of melanomas from fixed-tissue specimens, Plast Reconstr Surg, 88, 804, 10.1097/00006534-199111000-00010

Dauendorffer, 2009, Shrinkage of skin excision specimens: formalin fixation is not the culprit, Br J Dermatol, 4, 810, 10.1111/j.1365-2133.2008.08994.x

Epstein, 1973, How accurate is the visual assessment of basal carcinoma margins?, Br J Dermatol, 89, 37, 10.1111/j.1365-2133.1973.tb01915.x

Wolf, 1987, Surgical margins for basal cell carcinoma, Arch Dermatol, 123, 340, 10.1001/archderm.1987.01660270078019

Edens, 1983, Effectiveness of curettage and electrodesiccation in the removal of basal cell carcinoma, J Am Acad Dermatol, 9, 383, 10.1016/S0190-9622(83)70145-3

Gardner, 2001, Predictable tissue shrinkage during frozen section histopathologic processing for Mohs micrographic surgery, Dermatol Surg, 27, 813

Goldstein, 1999, Disparate surgical margin lengths of colorectal resection specimens between in vivo and in vitro measurements, Am J Clin Pathol, 111, 349, 10.1093/ajcp/111.3.349

Johnson, 1997, Quantification of surgical margin shrinkage in the oral cavity, Head Neck, 19, 281, 10.1002/(SICI)1097-0347(199707)19:4<281::AID-HED6>3.0.CO;2-X

Woodward, 2003, Terahertz pulse imaging of ex-vivo basal cell carcinoma, J Invest Dermatol, 120, 72, 10.1046/j.1523-1747.2003.12013.x

Gniadecka, 1997, Distinctive molecular abnormalities in benign and malignant skin lesions: studies by Raman spectroscopy, Photochem Photobiol, 66, 418, 10.1111/j.1751-1097.1997.tb03167.x

McIntosh, 1999, Infrared spectra of basal cell carcinomas are distinct from non-tumour-bearing components, J Invest Dermatol, 112, 951, 10.1046/j.1523-1747.1999.00612.x